Lymphoma Global Program Lead – VP, First-in-Class Degraders

Bristol Myers Squibb in Boudry, Switzerland, is looking for a Global Program Lead to guide first-in-class protein degraders for lymphoma. The role encompasses strategic planning, clinical trial design, and cross-functional leadership. Candidates should possess a minimum of 10 years in drug development and demonstrated leadership abilities. Compensation ranges from $341,360 to $413,648, complemented by comprehensive benefits including health coverage and paid time off.
#J-18808-Ljbffr